{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:55:02Z","timestamp":1793325302076,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guidance Project of Jiangsu Provincial Health Commission","award":["Z2023074"],"award-info":[{"award-number":["Z2023074"]}]},{"name":"Science Foundation of Kangda College of Nanjing Medical University","award":["KD2023KYJJ130"],"award-info":[{"award-number":["KD2023KYJJ130"]}]},{"name":"Suzhou Clinical Medical Center for Mood Disorders","award":["Szlcyxzx202109"],"award-info":[{"award-number":["Szlcyxzx202109"]}]},{"name":"Suzhou Key Laboratory","award":["SZS2024016"],"award-info":[{"award-number":["SZS2024016"]}]},{"name":"Suzhou Multicenter Clinical Research Project on Major Diseases","award":["DZXYJ202413, MR-32-25-054378"],"award-info":[{"award-number":["DZXYJ202413, MR-32-25-054378"]}]},{"name":"Yangzhou Basic Research Program (Joint Special Project) Health Project","award":["2024-2-19"],"award-info":[{"award-number":["2024-2-19"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07549-x","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:16:46Z","timestamp":1763461006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Associations of serum TNF-\u03b1, IL-8, and IL-18 levels with the clinical symptoms in acute schizophrenia: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Li","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"10323","key":"7549_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","volume":"399","author":"S Jauhar","year":"2022","unstructured":"Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399(10323):473\u201386.","journal-title":"Lancet"},{"key":"7549_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.schres.2024.06.032","volume":"270","author":"J Parnas","year":"2024","unstructured":"Parnas J, Sandsten KE. The phenomenological nature of schizophrenia and disorder of selfhood. Schizophr Res. 2024;270:197\u2013201.","journal-title":"Schizophr Res"},{"issue":"12","key":"7549_CR3","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","volume":"28","author":"M Solmi","year":"2023","unstructured":"Solmi M, Seitidis G, Mavridis D, Correll CU, Dragioti E, Guimond S, Tuominen L, Darg\u00e9l A, Carvalho AF, Fornaro M, et al. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the global burden of disease (GBD) 2019. Mol Psychiatry. 2023;28(12):5319\u201327.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"7549_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mcna.2022.05.005","volume":"107","author":"J Faden","year":"2023","unstructured":"Faden J, Citrome L. Schizophrenia: one Name, many different manifestations. Med Clin North Am. 2023;107(1):61\u201372.","journal-title":"Med Clin North Am"},{"issue":"1","key":"7549_CR5","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1017\/S1092852924000622","volume":"30","author":"JM Striebel","year":"2024","unstructured":"Striebel JM. What is schizophrenia - symptomatology. CNS Spectr. 2024;30(1):e12.","journal-title":"CNS Spectr"},{"key":"7549_CR6","doi-asserted-by":"publisher","first-page":"113767","DOI":"10.1016\/j.psychres.2021.113767","volume":"298","author":"L Phahladira","year":"2021","unstructured":"Phahladira L, Asmal L, L\u00fcckhoff HK, du Plessis S, Scheffler F, Kilian S, Smit R, Buckle C, Chiliza B, Emsley R. The course and concomitants of depression in first-episode schizophrenia spectrum disorders: A 24-month longitudinal study. Psychiatry Res. 2021;298:113767.","journal-title":"Psychiatry Res"},{"key":"7549_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2023.11.015","volume":"264","author":"R Tandon","year":"2024","unstructured":"Tandon R, Nasrallah H, Akbarian S, Carpenter WT Jr., DeLisi LE, Gaebel W, Green MF, Gur RE, Heckers S, Kane JM, et al. The schizophrenia syndrome, circa 2024: what we know and how that informs its nature. Schizophr Res. 2024;264:1\u201328.","journal-title":"Schizophr Res"},{"issue":"2","key":"7549_CR8","doi-asserted-by":"publisher","first-page":"e12486","DOI":"10.1111\/appy.12486","volume":"14","author":"JJ Yeo","year":"2022","unstructured":"Yeo JJ, Chew QH, Sim K. Resilience and its inter-relationship with symptomatology, illness course, psychosocial functioning, and mediational roles in schizophrenia: A systematic review. Asia-Pacific Psychiatry: Official J Pac Rim Coll Psychiatrists. 2022;14(2):e12486.","journal-title":"Asia-Pacific Psychiatry: Official J Pac Rim Coll Psychiatrists"},{"key":"7549_CR9","doi-asserted-by":"publisher","first-page":"114926","DOI":"10.1016\/j.psychres.2022.114926","volume":"317","author":"A Mayeli","year":"2022","unstructured":"Mayeli A, Clancy KJ, Sonnenschein S, Sarpal DK, Ferrarelli F. A narrative review of treatment interventions to improve cognitive performance in schizophrenia, with an emphasis on at-risk and early course stages. Psychiatry Res. 2022;317:114926.","journal-title":"Psychiatry Res"},{"key":"7549_CR10","doi-asserted-by":"crossref","unstructured":"Maes M, Plaimas K, Suratanee A, Noto C, Kanchanatawan B. First episode psychosis and schizophrenia are systemic neuro-immune disorders triggered by a biotic stimulus in individuals with reduced immune regulation and neuroprotection. Cells 2021, 10(11).","DOI":"10.3390\/cells10112929"},{"key":"7549_CR11","doi-asserted-by":"crossref","unstructured":"Malashenkova IK, Ushakov VL, Zakharova NV, Krynskiy SA, Ogurtsov DP, Hailov NA, Chekulaeva EI, Ratushnyy AY, Kartashov SI, Kostyuk GP, et al. Neuro-immune aspects of schizophrenia with severe negative symptoms: new diagnostic markers of disease phenotype. Sovremennye Tehnologii V Med 2021, 13(6).","DOI":"10.17691\/stm2021.13.6.03"},{"key":"7549_CR12","doi-asserted-by":"crossref","unstructured":"Rauf A, Badoni H, Abu-Izneid T, Olatunde A, Rahman MM, Painuli S, Semwal P, Wilairatana P, Mubarak MS. Neuroinflammatory markers: key indicators in the pathology of neurodegenerative diseases. Molecules 2022, 27(10).","DOI":"10.3390\/molecules27103194"},{"issue":"1","key":"7549_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000542888","volume":"84","author":"T Bellaagh Johansson","year":"2025","unstructured":"Bellaagh Johansson T, Klahn AL, G\u00f6teson A, Ab\u00e9 C, Sellgren CM, Land\u00e9n M. Cerebrospinal fluid biomarkers of central nervous system inflammation predict cortical decline in bipolar disorder and ventricular enlargement in healthy controls. Neuropsychobiology. 2025;84(1):38\u201347.","journal-title":"Neuropsychobiology"},{"key":"7549_CR14","doi-asserted-by":"crossref","unstructured":"Begum E, Mahmod MR, Rahman MM, Fukuma F, Urano T, Fujita Y. IL-18 blockage reduces neuroinflammation and promotes functional recovery in a mouse model of spinal cord injury. Biomolecules 2024, 15(1).","DOI":"10.3390\/biom15010016"},{"key":"7549_CR15","doi-asserted-by":"crossref","unstructured":"Gonzalez Caldito N. Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders. Front Immunol 2023, 14.","DOI":"10.3389\/fimmu.2023.1213448"},{"key":"7549_CR16","doi-asserted-by":"publisher","first-page":"1026670","DOI":"10.3389\/fonc.2022.1026670","volume":"12","author":"S Chen","year":"2022","unstructured":"Chen S, Chen M. Schwann cells promote the migration and invasion of colorectal cancer cells via the activated NF-\u03baB\/IL-8 axis in the tumor microenvironment. Front Oncol. 2022;12:1026670.","journal-title":"Front Oncol"},{"issue":"2","key":"7549_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1247\/csf.27.99","volume":"27","author":"SA Sarkar","year":"2002","unstructured":"Sarkar SA, Sharma RP. Expression of selected apoptosis related genes, MIF, IGIF and TNF alpha, during retinoic acid-induced neural differentiation in murine embryonic stem cells. Cell Struct Funct. 2002;27(2):99\u2013107.","journal-title":"Cell Struct Funct"},{"key":"7549_CR18","doi-asserted-by":"crossref","unstructured":"Wang X, Chen W, Gou M, Li W, Li N, Tong J, Zhou Y, Xie T, Yu T, Feng W, et al. Relationship between plasma TNF-\u03b1 levels and agitation symptoms in first episode patients with schizophrenia. BMC Psychiatry 2024, 24(1).","DOI":"10.1186\/s12888-024-05796-y"},{"issue":"1","key":"7549_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12888-024-05621-6","volume":"24","author":"H Yang","year":"2024","unstructured":"Yang H, Peng R, Yang M, Zhang J, Shi Z, Zhang X. Association between elevated serum matrix metalloproteinase-2 and tumor necrosis factor-alpha, and clinical symptoms in male patients with treatment-resistant and chronic medicated schizophrenia. BMC Psychiatry. 2024;24(1):173.","journal-title":"BMC Psychiatry"},{"key":"7549_CR20","doi-asserted-by":"publisher","first-page":"110173","DOI":"10.1016\/j.pnpbp.2020.110173","volume":"106","author":"SJ Tsai","year":"2021","unstructured":"Tsai SJ. Role of Interleukin 8 in depression and other psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2021;106:110173.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"7549_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12888-024-06163-7","volume":"24","author":"X Zhao","year":"2024","unstructured":"Zhao X, Zhu W, Bu Y, Li J, Hao Y, Bi Y. Effects of 6-week olanzapine treatment on serum IL-2, IL-4, IL-8, IL-10, and TNF-\u03b1 levels in drug-naive individuals with first-episode schizophrenia. BMC Psychiatry. 2024;24(1):703.","journal-title":"BMC Psychiatry"},{"key":"7549_CR22","doi-asserted-by":"publisher","first-page":"111018","DOI":"10.1016\/j.pnpbp.2024.111018","volume":"133","author":"J Yan","year":"2024","unstructured":"Yan J, Xia Q, Sun X, Yang P, Gao H, Pan Z, Gao J, Zhang L, Wang M, Wang K, et al. Dysregulation of interleukin-8 is involved in the onset and relapse of schizophrenia: an independent validation and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2024;133:111018.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7549_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbi.2021.10.017","volume":"99","author":"A Szabo","year":"2022","unstructured":"Szabo A, O\u2019Connell KS, Ueland T, Sheikh MA, Agartz I, Andreou D, Aukrust P, Boye B, B\u00f8en E, Drange OK, et al. Increased Circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation. Brain Behav Immun. 2022;99:299\u2013306.","journal-title":"Brain Behav Immun"},{"key":"7549_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.comppsych.2019.01.003","volume":"90","author":"Y Luo","year":"2019","unstructured":"Luo Y, He H, Zhang J, Ou Y, Fan N. Changes in serum TNF-\u03b1, IL-18, and IL-6 concentrations in patients with chronic schizophrenia at admission and at discharge. Compr Psychiatry. 2019;90:82\u20137.","journal-title":"Compr Psychiatry"},{"issue":"2","key":"7549_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.30773\/pi.2024.0078","volume":"22","author":"W Cho","year":"2025","unstructured":"Cho W, Kim S-W, Won S-H, Lee B-J, Tsujino N, Takubo Y, Yamaguchi T, Nemoto T, Li L, Le T-H, et al. Effects of the diagnostic and statistical manual of mental disorders, fifth edition criteria changes for schizophrenia on diagnoses of First-Episode schizophrenia spectrum disorders. Psychiatry Invest. 2025;22(2):212\u20137.","journal-title":"Psychiatry Invest"},{"issue":"1","key":"7549_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.schres.2013.04.026","volume":"150","author":"D Malaspina","year":"2013","unstructured":"Malaspina D, Owen MJ, Heckers S, Tandon R, Bustillo J, Schultz S, Barch DM, Gaebel W, Gur RE, Tsuang M, et al. Schizoaffective disorder in the DSM-5. Schizophr Res. 2013;150(1):21\u20135.","journal-title":"Schizophr Res"},{"issue":"7","key":"7549_CR27","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s11606-022-07980-w","volume":"38","author":"LJ Hunt","year":"2022","unstructured":"Hunt LJ, Covinsky KE, Cenzer I, Espejo E, Boscardin WJ, Leutwyler H, Lee AK, Cataldo J. The epidemiology of smoking in older adults: A National cohort study. J Gen Intern Med. 2022;38(7):1697\u2013704.","journal-title":"J Gen Intern Med"},{"key":"7549_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpsychires.2019.05.008","volume":"115","author":"A Shafer","year":"2019","unstructured":"Shafer A, Dazzi F. Meta-analysis of the positive and negative syndrome scale (PANSS) factor structure. J Psychiatr Res. 2019;115:113\u201320.","journal-title":"J Psychiatr Res"},{"key":"7549_CR29","doi-asserted-by":"crossref","unstructured":"Lim K, Peh O-H, Yang Z, Rekhi G, Rapisarda A, See Y-M, Rashid NAA, Ang M-S, Lee S-A, Sim K, et al. Large-scale evaluation of the positive and negative syndrome scale (PANSS) symptom architecture in schizophrenia. Asian J Psychiatry 2021, 62.","DOI":"10.1016\/j.ajp.2021.102732"},{"key":"7549_CR30","doi-asserted-by":"publisher","first-page":"113054","DOI":"10.1016\/j.psychres.2020.113054","volume":"290","author":"S Sakanaka","year":"2020","unstructured":"Sakanaka S, Tsujii N, Morimoto H, Shirakawa O. Aggressiveness is associated with excitement on the five-factor model of the positive and negative syndrome scale and prefrontal function in patients with stable schizophrenia. Psychiatry Res. 2020;290:113054.","journal-title":"Psychiatry Res"},{"issue":"4","key":"7549_CR31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","volume":"10","author":"S Halstead","year":"2023","unstructured":"Halstead S, Siskind D, Amft M, Wagner E, Yakimov V, Shih-Jung Liu Z, Walder K, Warren N. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2023;10(4):260\u201371.","journal-title":"Lancet Psychiatry"},{"key":"7549_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jpsychires.2023.07.014","volume":"165","author":"XX Goh","year":"2023","unstructured":"Goh XX, Tang PY, Tee SF. Meta-analysis of soluble tumour necrosis factor receptors in severe mental illnesses. J Psychiatr Res. 2023;165:180\u201390.","journal-title":"J Psychiatr Res"},{"key":"7549_CR33","doi-asserted-by":"publisher","first-page":"110740","DOI":"10.1016\/j.pnpbp.2023.110740","volume":"125","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang J, Ye Y, Zou Y, Chen W, Wang Z, Zou Z. Peripheral cytokine levels across psychiatric disorders: A systematic review and network meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2023;125:110740.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"7549_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/schbul\/sbx035","volume":"44","author":"AK Wang","year":"2018","unstructured":"Wang AK, Miller BJ. Meta-analysis of cerebrospinal fluid cytokine and Tryptophan catabolite alterations in psychiatric patients: comparisons between Schizophrenia, bipolar Disorder, and depression. Schizophr Bull. 2018;44(1):75\u201383.","journal-title":"Schizophr Bull"},{"issue":"4","key":"7549_CR35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/schbul\/sby125","volume":"45","author":"D Fraguas","year":"2019","unstructured":"Fraguas D, D\u00edaz-Caneja CM, Ayora M, Hern\u00e1ndez-\u00c1lvarez F, Rodr\u00edguez-Quiroga A, Recio S, Leza JC, Arango C. Oxidative stress and inflammation in First-Episode psychosis: A systematic review and Meta-analysis. Schizophr Bull. 2019;45(4):742\u201351.","journal-title":"Schizophr Bull"},{"key":"7549_CR36","doi-asserted-by":"crossref","unstructured":"Leboyer M, Godin O, Terro E, Boukouaci W, Lu C-l, Andre M, Aouizerate B, Berna F, Barau C, Capdevielle D, et al. Immune signatures of Treatment-Resistant schizophrenia: A fondamental academic centers of expertise for schizophrenia (FACE-SZ) study. Schizophrenia Bull Open 2021, 2(1).","DOI":"10.1093\/schizbullopen\/sgab012"},{"key":"7549_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.euroneuro.2023.04.003","volume":"73","author":"PLB Martins","year":"2023","unstructured":"Martins PLB, Moura IA, Mendes G, Ribeiro V, Arnaud A, Gama CS, Maes M, Macedo DS, Pinto JP. Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: A meta-analysis. Eur Neuropsychopharmacology: J Eur Coll Neuropsychopharmacol. 2023;73:82\u201395.","journal-title":"Eur Neuropsychopharmacology: J Eur Coll Neuropsychopharmacol"},{"issue":"3","key":"7549_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.euroneuro.2014.12.002","volume":"25","author":"M Capannolo","year":"2015","unstructured":"Capannolo M, Fasciani I, Romeo S, Aloisi G, Rossi M, Bellio P, Celenza G, Cinque B, Cifone MG, Scarselli M, et al. The atypical antipsychotic clozapine selectively inhibits Interleukin 8 (IL-8)-induced neutrophil chemotaxis. Eur Neuropsychopharmacology: J Eur Coll Neuropsychopharmacol. 2015;25(3):413\u201324.","journal-title":"Eur Neuropsychopharmacology: J Eur Coll Neuropsychopharmacol"},{"issue":"4","key":"7549_CR39","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/eip.13031","volume":"15","author":"AAS Syed","year":"2021","unstructured":"Syed AAS, He L, Shi Y, Mahmood S. Elevated levels of IL-18 associated with schizophrenia and first episode psychosis: A systematic review and meta-analysis. Early Interv Psychiat. 2021;15(4):896\u2013905.","journal-title":"Early Interv Psychiat"},{"key":"7549_CR40","doi-asserted-by":"crossref","unstructured":"Zhang Y, Luo L, Xu X, Wu J, Wang F, Lu Y, Zhang N, Ding Y, Lu B, Zhao K. Acetylation is required for full activation of the NLRP3 inflammasome. Nat Commun 2023, 14(1).","DOI":"10.1038\/s41467-023-44203-0"},{"key":"7549_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbi.2018.06.010","volume":"73","author":"FJ Herman","year":"2018","unstructured":"Herman FJ, Pasinetti GM. Principles of inflammasome priming and inhibition: implications for psychiatric disorders. Brain Behav Immun. 2018;73:66\u201384.","journal-title":"Brain Behav Immun"},{"key":"7549_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.schres.2022.12.049","volume":"252","author":"GE Hoprekstad","year":"2023","unstructured":"Hoprekstad GE, Kjelby E, Gjestad R, Fathian F, Larsen TK, Reitan SK, Rettenbacher M, Torsvik A, Skrede S, Johnsen E, et al. Depression trajectories and cytokines in schizophrenia spectrum disorders - A longitudinal observational study. Schizophr Res. 2023;252:77\u201387.","journal-title":"Schizophr Res"},{"issue":"11","key":"7549_CR43","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1038\/s41380-022-01737-x","volume":"27","author":"GM Kemp","year":"2022","unstructured":"Kemp GM, Altimimi HF, Nho Y, Heir R, Klyczek A, Stellwagen D. Sustained TNF signaling is required for the synaptic and anxiety-like behavioral response to acute stress. Mol Psychiatry. 2022;27(11):4474\u201384.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"7549_CR44","first-page":"395","volume":"77","author":"M Pavlovic","year":"2023","unstructured":"Pavlovic M, Babic D, Rastovic P, Arapovic J, Martinac M, Jakovac S, Barbaric R. Association of tumor necrosis Factor-Alpha with psychopathology in patients with schizophrenia. Acta Med Okayama. 2023;77(4):395\u2013405.","journal-title":"Acta Med Okayama"},{"issue":"5","key":"7549_CR45","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00406-024-01885-x","volume":"275","author":"Y Li","year":"2025","unstructured":"Li Y, Zhu M, Dong Y, Liu N, Wang X, Yang B, Li Z, Li S. Immunoinflammatory features and cognitive function in treatment-resistant schizophrenia: unraveling distinct patterns in clozapine-resistant patients. Eur Arch Psychiatry Clin Neurosci. 2025;275(5):1391\u2013401.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"7549_CR46","doi-asserted-by":"crossref","unstructured":"Kazmi N, Wallen GR, Yang L, Alkhatib J, Schwandt ML, Feng D, Gao B, Diazgranados N, Ramchandani VA, Barb JJ. An exploratory study of pro-inflammatory cytokines in individuals with alcohol use disorder: MCP-1 and IL-8 associated with alcohol consumption, sleep quality, anxiety, depression, and liver biomarkers. Front Psychiatry 2022, 13.","DOI":"10.3389\/fpsyt.2022.931280"},{"key":"7549_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jad.2022.09.044","volume":"319","author":"DJ Bond","year":"2022","unstructured":"Bond DJ, Andreazza AC, Torres IJ, Honer WG, Lam RW, Yatham LN. Association of total peripheral inflammation with lower frontal and Temporal lobe volumes in early-stage bipolar disorder: A proof-of-concept study. J Affect Disord. 2022;319:229\u201334.","journal-title":"J Affect Disord"},{"issue":"6","key":"7549_CR48","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/ejn.16123","volume":"59","author":"H Sotoyama","year":"2024","unstructured":"Sotoyama H. Putative neural mechanisms underlying release-mode-specific abnormalities in dopamine neural activity in a schizophrenia-like model: the distinct roles of glutamate and serotonin in the impaired regulation of dopamine neurons. Eur J Neurosci. 2024;59(6):1194\u2013212.","journal-title":"Eur J Neurosci"},{"key":"7549_CR49","doi-asserted-by":"publisher","first-page":"114791","DOI":"10.1016\/j.bbr.2023.114791","volume":"459","author":"H Alizadeh Pahlavani","year":"2024","unstructured":"Alizadeh Pahlavani H. Possible role of exercise therapy on depression: effector neurotransmitters as key players. Behav Brain Res. 2024;459:114791.","journal-title":"Behav Brain Res"},{"key":"7549_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.psychres.2018.04.036","volume":"265","author":"A Mohammadi","year":"2018","unstructured":"Mohammadi A, Rashidi E, Amooeian VG. Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia. Psychiatry Res. 2018;265:25\u201338.","journal-title":"Psychiatry Res"},{"key":"7549_CR51","doi-asserted-by":"crossref","unstructured":"Mednova IA, Boiko AS, Kornetova EG, Semke AV, Bokhan NA, Ivanova SA. Cytokines as potential biomarkers of clinical characteristics of schizophrenia. Life 2022, 12(12).","DOI":"10.3390\/life12121972"},{"key":"7549_CR52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbi.2022.05.017","volume":"104","author":"J Zhou","year":"2022","unstructured":"Zhou J, Teng Y, Zhang F, Ru X, Li P, Wang J, Yan S, Zhu P, Tao F, Huang K. Sex-specific association between placental inflammatory cytokine mRNA expression and preschoolers\u2019 behavioral development: the ma\u2019anshan birth cohort study. Brain Behav Immun. 2022;104:110\u201321.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"7549_CR53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41537-023-00398-1","volume":"9","author":"H Kim","year":"2023","unstructured":"Kim H, Baek SH, Kim JW, Ryu S, Lee JY, Kim JM, Chung YC, Kim SW. Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia. Schizophrenia (Heidelb). 2023;9(1):68.","journal-title":"Schizophrenia (Heidelb)"},{"key":"7549_CR54","doi-asserted-by":"crossref","unstructured":"Akhter N, Wilson A, Thomas R, Al-Rashed F, Kochumon S, Al-Roub A, Arefanian H, Al-Madhoun A, Al-Mulla F, Ahmad R, et al. ROS\/TNF-\u03b1 crosstalk triggers theexpression of IL-8 and MCP-1 in human monocytic THP-1 cells via the NF-\u03baB and ERK1\/2 mediated signaling. Int J Mol Sci. 2021;22(19).","DOI":"10.3390\/ijms221910519"},{"key":"7549_CR55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bbi.2015.09.014","volume":"51","author":"XY Zhang","year":"2016","unstructured":"Zhang XY, Tan YL, Chen DC, Tan SP, Yang FD, Wu HE, Zunta-Soares GB, Huang XF, Kosten TR, Soares JC. Interaction of BDNF with cytokines in chronic schizophrenia. Brain Behav Immun. 2016;51:169\u201375.","journal-title":"Brain Behav Immun"},{"key":"7549_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2020.12.020","volume":"230","author":"D Enache","year":"2021","unstructured":"Enache D, Nikkheslat N, Fathalla D, Morgan BP, Lewis S, Drake R, Deakin B, Walters J, Lawrie SM, Egerton A, et al. Peripheral immune markers and antipsychotic non-response in psychosis. Schizophr Res. 2021;230:1\u20138.","journal-title":"Schizophr Res"},{"key":"7549_CR57","doi-asserted-by":"publisher","first-page":"110926","DOI":"10.1016\/j.pnpbp.2023.110926","volume":"130","author":"W Chen","year":"2024","unstructured":"Chen W, Tian Y, Gou M, Wang L, Tong J, Zhou Y, Feng W, Li Y, Chen S, Liu Y, et al. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2024;130:110926.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"7549_CR58","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41423-019-0296-z","volume":"18","author":"X Unamuno","year":"2019","unstructured":"Unamuno X, G\u00f3mez-Ambrosi J, Ram\u00edrez B, Rodr\u00edguez A, Becerril S, Valent\u00ed V, Moncada R, Silva C, Salvador J, Fr\u00fchbeck G, et al. NLRP3 inflammasome Blockade reduces adipose tissue inflammation and extracellular matrix remodeling. Cell Mol Immunol. 2019;18(4):1045\u201357.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"7549_CR59","first-page":"193","volume":"19","author":"I Nedeva","year":"2022","unstructured":"Nedeva I, Gateva A, Assyov Y, Karamfilova V, Hristova J, Yamanishi K, Kamenov Z, Okamura H. IL-18 serum levels in patients with Obesity, prediabetes and newly diagnosed type 2 diabetes. Iran J Immunology: IJI. 2022;19(2):193\u2013200.","journal-title":"Iran J Immunology: IJI"},{"issue":"1","key":"7549_CR60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cmet.2015.09.024","volume":"23","author":"AJ Murphy","year":"2016","unstructured":"Murphy AJ, Kraakman MJ, Kammoun HL, Dragoljevic D, Lee MK, Lawlor KE, Wentworth JM, Vasanthakumar A, Gerlic M, Whitehead LW, et al. IL-18 production from the NLRP1 inflammasome prevents obesity and metabolic syndrome. Cell Metab. 2016;23(1):155\u201364.","journal-title":"Cell Metab"},{"key":"7549_CR61","doi-asserted-by":"crossref","unstructured":"Barcena ML, Tonini G, Haritonow N, Breiter P, Milting H, Baczko I, M\u00fcller-Werdan U, Ladilov Y, Regitz\u2010Zagrosek V. Sex and age differences in AMPK phosphorylation, mitochondrial homeostasis, and inflammation in hearts from inflammatory cardiomyopathy patients. Aging Cell 2023, 22(8).","DOI":"10.1111\/acel.13894"},{"issue":"4","key":"7549_CR62","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/psyg.12032","volume":"13","author":"M Yasuda","year":"2013","unstructured":"Yasuda M, Kobayashi T, Kato S, Kishi K. Clinical features of late-onset schizophrenia in japan: comparison with early-onset cases. Psychogeriatrics: Official J Japanese Psychogeriatr Soc. 2013;13(4):244\u20139.","journal-title":"Psychogeriatrics: Official J Japanese Psychogeriatr Soc"},{"issue":"1","key":"7549_CR63","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1017\/S1041610223000157","volume":"36","author":"DP Devanand","year":"2024","unstructured":"Devanand DP, Jeste DV, Stroup TS, Goldberg TE. Overview of late-onset psychoses. Int Psychogeriatr. 2024;36(1):28\u201342.","journal-title":"Int Psychogeriatr"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07549-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:04:39Z","timestamp":1763463879000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-07549-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7549"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07549-x","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Committee of Lianyungang Fourth People\u2019s Hospital (Approval No. 2021LSYYXLL-P03, dated March 4, 2021) and conducted in accordance with the ethical principles for medical research involving human subjects described in the Declaration of Helsinki. Prior to inclusion in this study, informed consent was obtained from all participants and\/or their legal guardians. All patients\u2019 capacity to consent was assessed by two independent psychiatrists through clinical evaluation of their understanding of the study purpose, procedures, potential risks and benefits, and their ability to make voluntary decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1096"}}